| 2026 |
Publication |
Mol Ther Advances
|
Neuro |
Christophe Lo Bianco, et al. Global age-related seroprevalence for adeno-associated virus serotype 9 immunoglobulin G. Mol Ther Advances. |
| 2026 |
Publication |
Blood Coagul Fibrinolysis |
Other |
Goujon MA, et al. Performance evaluation of Stago sthemO 301 hemostasis analyzer for routine testing, coagulation factors, and inhibitors. |
| 2026 |
Acknowlegment |
Vaccine |
Virology/Vaccines |
Davis M, et al. A Phase IIa randomized clinical trial of a respiratory syncytial virus and human metapneumovirus combination protein-based virus-like particle vaccine in adults 60-85 years of age. |
| 2025 |
Publication |
Int J Cancer
|
Solid Tumors |
Damgaard R, et al. p16INK4a and HPV E4 immunohistochemistry for the prediction of regression of cervical intraepithelial neoplasia grade 2-A historical cohort study. |
| 2025 |
Publication |
JID Innov
|
Rare |
Kravvas G, et al. A Direct Comparative Analysis of HPV DNA with Single-Molecule RNA and p16INK4a Protein Expression in Lichen Sclerosus: Implications for Diagnostics and Pathogenesis. |
| 2025 |
Publication |
Cytometry B Clin Cytom
|
Other |
Monaghan SA, et al. Flow cytometry assay modifications: Recommendations for method validation based on CLSI H62 guidelines. |
| 2025 |
Publication |
Int J Surg Pathol
|
Solid Tumors |
Fernández-Nestosa MJ, et al. Human Papillomavirus (HPV) Genotypes in Mixed Squamous Cell Carcinoma of the Penis: A Study of 101 Tumors. |
| 2025 |
Publication |
Lancet Infect Dis
|
Virology/Vaccines |
Kulkarni PS, et al. Safety and immunogenicity of a reduced-dose inactivated poliovirus vaccine versus a full-dose inactivated poliovirus vaccine in infants in Bangladesh: a double-blind, non-inferiority, randomised, controlled, phase 3 trial. |
| 2025 |
Publication |
Vaccines (Basel) |
COVID |
McMillan CLD, et al. Booster Immunisation with Skin-Patch-Delivered Unadjuvanted SARS-CoV-2 Spike Protein Vaccine Is Safe and Immunogenic in Healthy Adults. |
| 2025 |
Acknowlegment |
Nature |
Virology/Vaccines |
Ma C, et al. mmune correlates analysis of mRNA-1345 RSV vaccine efficacy clinical trial. |
| 2025 |
Acknowlegment |
Clin Infect Dis |
Virology/Vaccines |
Goswami J, et al. Safety and immunogenicity of mRNA-1345 RSV vaccine coadministered with an influenza or COVID-19 vaccine in adults aged 50 years or older: an observer-blinded, placebo-controlled, randomised, phase 3 trial. |
| 2025 |
Acknowlegment |
|
Virology/Vaccine |
Döhrmann S, et al.Drug–Fc conjugate CD388 targets influenza virus neuraminidase and is broadly protective in mice |
| 2025 |
Acknowlegment |
Sci Adv
|
COVID |
Lear TB, et al. Inhibition of virally induced TFEB proteasomal degradation as a host-centric therapeutic approach for coronaviral infection. |
| 2025 |
Publication |
Front Immunol
|
COVID |
Füll Y, et al. Antiviral and immunomodulatory effect of zapnometinib in animal models and hospitalized COVID-19 patients |
| 2025 |
Submitted |
Int J Cancer |
Solid Tumors |
Karien C.M, et al. HPV genotypes causing anal cancer differ between HIV+ and HIV- persons. |
| 2025 |
Publication |
J Clin Microbiol |
Anti-infectives |
Serge Diagbouga P, et al.Preliminary performance of the VIDAS TB-IGRA as an aid in the diagnosis of individuals infected with Mycobacterium tuberculosis |
| 2025 |
Publication |
J Infect Dis |
Virology/Vaccine |
Guilfoyle K, et al. Highly Pathogenic Avian Influenza Virus A/H5N1 Subclade 2.3.4.4b Isolated from a European Grey Seal (Halichoerus grypus) Is Highly Virulent in Ferrets. |
| 2025 |
Publication |
Int J Cancer |
Solid Tumors |
Damgaard R, et al.p16INK4a and HPV E4 immunohistochemistry for the prediction of regression of cervical intraepithelial neoplasia grade 2-A historical cohort study. |
| 2025 |
Publication
|
Lancet Infect Dis |
Virology/Vaccine |
Kulkarni PS, et al. Safety and immunogenicity of a reduced-dose inactivated poliovirus vaccine versus a full-dose inactivated poliovirus vaccine in infants in Bangladesh: a double-blind, non-inferiority, randomised, controlled, phase 3 trial |
| 2025 |
Publication |
Npj Viruses |
Virology/Vaccine |
Kolbe SM, et al.Syrian hamsters (Mesocricetus auratus) as an upper respiratory tract model for respiratory syncytial virus infection. |
| 2025 |
Publication |
Bioanalysis |
Other |
Yuan M, et al. Recommendations on biomarker assay validation (BAV) in tissues by GCC.
|
| 2025 |
Publication |
JID Innov |
Virology/Vaccine |
Kravvas G, et al.A Direct Comparative Analysis of HPV DNA with Single-Molecule RNA and p16INK4a Protein Expression in Lichen Sclerosus: Implications for Diagnostics and Pathogenesis. |
| 2025 |
Publication |
J Natl Cancer Inst |
Solid Tumors |
Adcock R, et al.HPV vaccine impact: genotype-specific changes in cervical pre-cancer share similarities with changes in cervical screening cytology. |
| 2025 |
Publication |
Oral Oncol |
Virology/Vaccine |
DSouza G, et al. Oral HPV incidence and risk factors for acquisition. |
| 2025 |
Publication |
Biologicals |
Virology/Vaccine |
Meln I, et al.Regulatory workshop on standardisation of clinical procedures, endpoints and data robustness of human challenge studies – A stakeholder meeting report. |
| 2025 |
Publication |
Bioanalysis |
Other |
Zimmer J, et al. Molecular effects of digital psychological intervention for perinatal stress: cell culture, animal model validation, and machine learning-based biomarker identification. |